Details of the Drug-Related molecule(s) Interaction Atlas

General Information of Drug (ID: DMOA4VW)

Drug Name
Insulin-detemir Drug Info
Synonyms
Insulin detemir; UNII-4FT78T86XV; 4FT78T86XV; NN-304; Levemir; Levemir Penfill; Levemir Insulin; Levemir Innolet; Levemir Flexpen; 169148-63-4; Insulin detemir [USAN:INN:BAN]; NN304; NN 304; CHEMBL2104391; INSULIN DETEMIR RECOMBINANT; 29B-(N6-Myristoyl-L-lysine)-30B-de-L-threonineinsulin (human); 29(sup B)-(N(sup 6)-Myristoyl-L-lysine)-30(sup B)-de-L-threonineinsulin (human); 29(sup B)-(N(sup 6)-(1-Oxotetradecyl)-L-lysine)-(1(sup A)-21(sup A)),(1(sup B)-29(sup B))-insulin (human); 270588-25-5
Indication
Disease Entry ICD 11 Status REF
Type-1/2 diabetes 5A10-5A11 Approved [1]
Therapeutic Class
Hypoglycemic Agents
Cross-matching ID
PubChem CID
16137271
CAS Number
CAS 169148-63-4
TTD Drug ID
DMOA4VW

Molecule-Related Drug Atlas

Molecule-Related Drug Atlas
Molecule Type:
DTT
Drug Status:
Approved Drug(s)
Clinical Trial Drug(s)
Download the Complete Related Drug List
Drug(s) Targeting Insulin (INS)
Drug Name Drug ID Indication ICD 11 Highest Status REF
Inulin DM1Y2JH Measure kidney function MG02 Approved [2]
Insulin Zinc Susp Recombinant Human DM6MO9X Diabetic complication 5A2Y Approved [2]
Insulin-glargine DMR4HIW Diabetic complication 5A2Y Approved [2]
Insulin Susp Isophane Recombinant Human DMW8KI7 Diabetic complication 5A2Y Approved [2]
Insulin determir DM79NZ5 Diabetic complication 5A2Y Approved [3]
Insulin Susp Protamine Zinc Beef/Pork DM0NATE Diabetic complication 5A2Y Approved [2]
Insulin-aspart DMX7V28 Diabetic complication 5A2Y Approved [2]
Insulin degludec DMPL395 Type-1/2 diabetes 5A10-5A11 Approved [4]
LY2963016 DMEZ0H5 Type-1/2 diabetes 5A10-5A11 Phase 3 [5]
SAR342434 DMR0EWV Diabetic complication 5A2Y Phase 3 [6]
⏷ Show the Full List of 10 Drug(s)

Molecular Interaction Atlas of This Drug

Molecular Interaction Atlas
Download the Complete Interaction Atlas for Visualization in Cytoscape

Drug Therapeutic Target (DTT)
DTT Name DTT ID UniProt ID MOA REF
Insulin (INS) TTZOPHG INS_HUMAN Modulator [2]

References

1 Natural products as sources of new drugs over the last 25 years. J Nat Prod. 2007 Mar;70(3):461-77.
2 Drugs@FDA. U.S. Food and Drug Administration. U.S. Department of Health & Human Services.
3 2005 approvals: Safety first. Nature Reviews Drug Discovery 5, 92-93 (February 2006).
4 Radium 223 dichloride for prostate cancer treatment. Drug Des Devel Ther. 2017 Sep 6;11:2643-2651.
5 Efficacy and safety of LY2963016 insulin glargine compared with insulin glargine (Lantus ) in patients with type 1 diabetes in a randomized controlled trial: the ELEMENT 1 study. Diabetes Obes Metab.2015 Aug;17(8):726-33.
6 Biosimilar insulins: a European perspective. Diabetes Obes Metab. 2015 May; 17(5): 445-451.